Clinical Trials in New York State

Showing 12101-12120 of 14,718 trials

Intranasal Midazolam in Children as a Pre-Operative Sedative

NCT02314546

The purpose of this study is to see if adding a numbing medicine, xylocaine, to the nasal midazolam makes giving the midazolam easier and more comfortable without affecting how the midazolam works as a sedative.

Sedation, Conscious

Bassett Healthcare15 participantsStarted Dec 2011

Cooperstown, New York, United States

COMPLETEDPhase 2106 miles

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

NCT01649297

The aim of this study is to investigate the efficacy and safety of two doses (high and low) of empagliflozin as add-on therapy to metformin in patients with type 2 diabetes mellitus (T2DM) and insufficient glycaemic control. Both doses may be given once daily or split to a twice daily dosage. This results in 4 different dosage regimens of empagliflozin (high dose once daily or split vs. low dose once daily or split). This is done to evaluate whether a twice daily dose regimen of empagliflozin results in a loss of efficacy relative to once daily dosing when given on top of metformin background therapy.

Diabetes Mellitus, Type 2

Boehringer Ingelheim983 participantsStarted Oct 2012

Florence, Alabama, United States • Jonesboro, Arkansas, United States • Lomita, California, United States +136 more locations

Intranasal Midazolam in Children as a Pre-Operative Sedative

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Find Trials by Condition in New York State

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS

Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device

A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)

A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA

SHORTness of Breath In the Emergency Department (SHORTIE)

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department

Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts

Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients

Improving Safety By Computerizing Outpatient Prescribing

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia